MedTrace Logo

Effect of Gemcabene on the Pharmacokinetics of Simvastatin in Healthy Volunteers

NCT02587390 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2020-04-09

No results posted yet for this study

Summary

The purpose of this study is to determine the effect of gemcabene on the pharmacokinetics of simvastatin 80 mg.

Conditions

Interventions

DRUG

Gemcabene 900 mg

3x300 mg Gemcabene tablets orally once daily (QD) for 15 days

DRUG

Simvastatin 80 mg

2x40 mg Simvastatin tablets orally once daily (QD) for 15 days

Sponsors & Collaborators

  • NeuroBo Pharmaceuticals Inc.

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2000-05-31
Primary Completion
2000-07-31
Completion
2000-07-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02587390 on ClinicalTrials.gov